A murine model for human immune thrombocytopenic purpura and comparative analysis of multiple gene expression in bone marrow and spleen

Journal of Genetics and Genomics

Volumn 35, Issue 11, 2008, Pages 665-671

  Wei, Hong ^a,b   Ding, Xinchun ^b,c   Ren, Jiangong ^b,c   Liu, Ka ^b,c   Tan, Pingping ^b   Li, Daquan ^a   Ma, Runlin Z ^b  

^a SHIHEZI UNIVERSITY   (China)

^b INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

immune thrombocytopenic purpura; murine model; semi quantative RT PCR

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; THROMBOCYTE COUNT;

ANIMALS; ANTIBODIES; BLOOD PLATELETS; BONE MARROW; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GUINEA PIGS; HUMANS; MALE; MICE; PURPURA, THROMBOCYTOPENIC; RNA, MESSENGER; SPLEEN; TIME FACTORS;

ANIMALIA; MAMMALIA; MURINAE;

EID: 55949105596     PISSN: 16738527     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-8527(08)60088-0     Document Type: Article

References (20)

1. Alexander W.S., Roberts A.W., Nicola N.A., Li R., and Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87 (1996) 2162-2170
2. Alves-Rosa F., Stanganelli C., Cabrera J., van Rooijen N., Palermo M.S., and Isturiz M.A. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 96 (2000) 2834-2840
3. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. New England J. Med. 346 (2002) 995-1008
4. Cohen-Solal K., Vitrat N., Titeux M., Vainchenker W., and Wendling F. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Blood 93 (1999) 2859-2866
5. Daw N.C., Arnold J.T., Abushullaih B.A., Stenberg P.E., White M.M., Jayawardene D., Srivastava D.K., and Jackson C.W. A single intravenous dose of murine megakaryocyte growth and development factor potently stimulates platelet production, challenging the necessity for daily administration. Blood 91 (1998) 466-474
6. de Botton S., Sabri S., Daugas E., Zermati Y., Guidotti J.E., Hermine O., Kroemer G., Vainchenker W., and Debili N. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100 (2002) 1310-1317
7. Jagerschmidt A., Fleury V., Anger-Leroy M., Thomas C., Agnel M., and O'Brien D.P. Human thrombopoietin structure-function relationships: Identification of functionally important residues. Biochem. J. 333 (1998) 729-734
8. Kaluzhny Y., Yu G., Sun S., Toselli P.A., Nieswandt B., Jackson C.W., and Ravid K. BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. Blood 100 (2002) 1670-1678
9. Kato T., Matsumoto A., Ogami K., Tahara T., Morita H., and Miyazaki H. Native thrombopoietin: Structure and function. Stem Cells 16 (1998) 322-328
10. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 115 (2005) 3339-3347
11. Levin J., Peng J.P., Baker G.R., Villeval J.L., Lecine P., Burstein S.A., and Shivdasani R.A. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood 94 (1999) 3037-3047
12. Mason K.D., Carpinelli M.R., Fletcher J.I., Collinge J.E., Hilton A.A., Ellis S., Kelly P.N., Ekert P.G., Metcalf D., Roberts A.W., Huang D.S., and Kile B.T. Programmed anuclear cell death delimits platelet life span. Cell 128 (2007) 1173-1186
13. Metcalf D., Carpinelli M.R., Hyland C., Mifsud S., Dirago L., Nicola N.A., Hilton D.J., and Alexander W.S. Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene. Blood 105 (2005) 3480-3487
14. Mouzaki A., Theodoropoulou M., Gianakopoulos I., Vlaha V., Kyrtsonis M.C., and Maniatis A. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: Their role in prognosis. Blood 100 (2002) 1774-1779
15. Musaji A., Vanhoorelbeke K., Deckmyn H., and Coutelier J.P. New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. Exp. Hematol. 32 (2004) 87-94
16. NIH. (1985). Guide for the care and use of laboratory animals (NIH Publication).
17. Patel S.R., Hartwig J.H., and Italiano Jr. J.E. The biogenesis of platelets from megakaryocyte proplatelets. J. Clin. Invest. 115 (2005) 3348-3354
18. Shivdasani R.A., Fujiwara Y., McDevitt M.A., and Orkin S.H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16 (1997) 3965-3973
19. Triplett D.A. Coagulation and bleeding disorders: Review and update. Clin. Chem. 46 (2000) 1260-1269
20. Zhou W., Toombs C.F., Zou T., Guo J., and Robinson M.O. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 89 (1997) 1551-1559